南药产品
首页 > 南药产品 > 专题产品 > 正文

磺胺多辛乙胺嘧啶片(Sulfadoxine and Pyrimethamine Tablet)

发布时间:2014-08-20

DESCRIPTION 】White round tablets marked “SP” on both sides and a score line on one side.  
  

【INDICATIONS】

Sulfadoxine and Pyrimethamine tablets are indicated for Intermittent Preventive Treatment(IPT) of malaria in pregnancy.

(1) IPT is recommended in areas of high malaria transmission.

(2) IPT is administered with each scheduled visit after quickening to ensure at least 2 doses are given.

(3) Women known to be HIV-Infected or with unknown HIV status living in areas of high HIV prevelance(>10% among pregnant women) should receive at least 3 doses of IPT.

(4) IPT should be given at an interval of at least 4 weeks (1 month).

(5) Pregnant women who are HIV positive and are also taking antiretroviral therapy for PMTCT should receive IPT.

Sulfadoxine and Pyrimethamine tablet is also recommended as an adjunctive therapy to be used on the last day of oral quinine sulphate therapy in the treatment of severe malarial infections for optimal clinical response.

 
  

【DOSAGE AND ADMINISTRATION】

Sulfadoxine and Pyrimethamine tablet is for oral administration. The usual dose is 25mg of SULFA component per kg body weight as a single dose for IPT.

Adjunctive Therapy

One dose of G-COSPETM taken as follows:

Adults

> 50 kg

3 tablets

5-10 kg

0.5 tablet

11-14 kg

0.75 tablet

15-20 kg

1 tablet

21-30 kg

1.5 tablet

31-40 kg

2 tablets

41-50 kg

2.5 tablets

It is advisable that intake of electrolytes and body fluids are maintained

 
  

PACKAGE: (1) The primary packs are blister cards (comprised of colorless transparent PVC blisters sealed with an aluminium foil lid) of 3 tablets of SP tablets.

Pack size: 3 tablets/blister×100 blisters packed in cardboard boxes & 3 tablets/blister×1 blisters packed in cardboard boxes

(2) The primary packs are PE jar for medicine use of 1000 tablets of SP tablets.

Pack size: 1000 tablets/jar